{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:23:11Z","timestamp":1780413791461,"version":"3.54.1"},"reference-count":30,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Primary hyperparathyroidism (PHPT) is a common endocrine disorder for which minimally invasive parathyroidectomy (MIP) is the standard surgical approach. Intraoperative parathyroid hormone (IOPTH) monitoring is commonly performed using second-generation (2G) parathyroid hormone (PTH) assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the performance of IOPTH central sampling peripheral sampling, and third-generation (3G) vs 2G assays in patients with PHPT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a prospective cohort study conducted at American University of Beirut Medical Center, a tertiary hospital in Beirut, Lebanon. The study included 68 subjects with confirmed PHPT who achieved surgical cure, defined as normocalcemia at \u22656 months. IOPTH levels were measured from central and peripheral venous samples using 2G and 3G assays at various time points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age was 57 years, and 80% were female. One-fourth had osteoporosis or reported kidney stones. Median preoperative calcium was 10.8\u2005mg\/dL with PTH 104\u2005pg\/mL, and 82% had single-gland disease. IOPTH levels were significantly higher with 2G assay and central sampling vs 3G assay and peripheral sampling. The proportion of patients meeting the Miami criterion did not differ between assays or sampling sites. Median percentage drop in IOPTH was greater with the 3G assay compared to 2G, across all time points, at both sampling sites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although both assays similarly identified a \u226550% intraoperative decline, 3G assays demonstrated a steeper and more consistent drop, suggesting that higher assay-specific thresholds may improve decision-making. Central and peripheral sampling showed comparable predictive performance, although central sampling may allow earlier detection of PTH decline.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvag109","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:58:22Z","timestamp":1779868702000},"source":"Crossref","is-referenced-by-count":1,"title":["Intraoperative PTH monitoring: does sampling site or assay generation matter?"],"prefix":"10.1210","volume":"10","author":[{"given":"Rola","family":"Kwayess","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Indiana University, School of Medicine , Indianapolis, IN 46202 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ajjour","sequence":"additional","affiliation":[{"name":"Calcium Metabolism and Osteoporosis Program, Department of Internal Medicine, American University of Beirut Medical Center , Beirut 1107 2020 ,","place":["Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9467-5062","authenticated-orcid":false,"given":"Maya","family":"Rahme","sequence":"additional","affiliation":[{"name":"Calcium Metabolism and Osteoporosis Program, Department of Internal Medicine, American University of Beirut Medical Center , Beirut 1107 2020 ,","place":["Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Assaad","sequence":"additional","affiliation":[{"name":"Calcium Metabolism and Osteoporosis Program, Department of Internal Medicine, American University of Beirut Medical Center , Beirut 1107 2020 ,","place":["Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0012-986X","authenticated-orcid":false,"given":"Marlene","family":"Chakhtoura","sequence":"additional","affiliation":[{"name":"Calcium Metabolism and Osteoporosis Program, Department of Internal Medicine, American University of Beirut Medical Center , Beirut 1107 2020 ,","place":["Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-2821","authenticated-orcid":false,"given":"Omar","family":"Kreidieh","sequence":"additional","affiliation":[{"name":"Tulane Research Innovation for Arrhythmia Discovery (TRIAD), Tulane University School of Medicine , New Orleans, LA 70112 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaber","family":"Abbas","sequence":"additional","affiliation":[{"name":"American University of Beirut Medical Center , Beirut 1107 2020 ,","place":["Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Jabbour-Khoury","sequence":"additional","affiliation":[{"name":"American University of Beirut Medical Center , Beirut 1107 2020 ,","place":["Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose T","family":"Daher","sequence":"additional","affiliation":[{"name":"American University of Beirut Medical Center , Beirut 1107 2020 ,","place":["Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Cavalier","sequence":"additional","affiliation":[{"name":"University of Liege , Liege 4000 ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2076-5858","authenticated-orcid":false,"given":"Ghada","family":"El-Hajj Fuleihan","sequence":"additional","affiliation":[{"name":"Calcium Metabolism and Osteoporosis Program, Department of Internal Medicine, American University of Beirut Medical Center , Beirut 1107 2020 ,","place":["Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"11","key":"2026060202462395300_bvag109-B1","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2026060202462395300_bvag109-B2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"issue":"11","key":"2026060202462395300_bvag109-B3","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/jbmr.4689","article-title":"Surgical aspects of primary hyperparathyroidism","volume":"37","author":"Perrier","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2026060202462395300_bvag109-B4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/cen.13882","article-title":"Impact of intraoperative parathyroid hormone monitoring on the management of patients with primary hyperparathyroidism","volume":"90","author":"Shawky","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026060202462395300_bvag109-B5","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.surg.2004.06.043","article-title":"The influence of sample site on intraoperative PTH monitoring during parathyroidectomy","volume":"136","author":"Woodrum","year":"2004","journal-title":"Surgery"},{"issue":"5","key":"2026060202462395300_bvag109-B6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00423-009-0510-z","article-title":"Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy","volume":"394","author":"Barczynski","year":"2009","journal-title":"Langenbeck's Archives of Surgery"},{"issue":"2","key":"2026060202462395300_bvag109-B7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/jamaoto.2020.4021","article-title":"Use of intraoperative parathyroid hormone in minimally invasive parathyroidectomy for primary hyperparathyroidism: a systematic review and meta-analysis","volume":"147","author":"Quinn","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"6","key":"2026060202462395300_bvag109-B8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.surg.2003.06.001","article-title":"Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate?","volume":"134","author":"Carneiro","year":"2003","journal-title":"Surgery"},{"key":"2026060202462395300_bvag109-B9","doi-asserted-by":"crossref","first-page":"5496710","DOI":"10.1155\/2019\/5496710","article-title":"Parathyroid hormone measurement in chronic kidney disease: from basics to clinical implications","volume":"2019","author":"Kritmetapak","year":"2019","journal-title":"Int J Nephrol"},{"key":"2026060202462395300_bvag109-B10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cca.2017.12.012","article-title":"Spurious intraoperative PTH results observed with 2(nd), but not with 3(rd) generation PTH assays","volume":"477","author":"Cavalier","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2026060202462395300_bvag109-B11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1245\/s10434-010-1375-7","article-title":"Changing intraoperative parathyroid hormone collection sites from peripheral to central does not affect predictive accuracy during minimally invasive parathyroidectomy","volume":"18","author":"Abdel-Misih","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"2026060202462395300_bvag109-B12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026060202462395300_bvag109-B13","volume-title":"Endocrine and Neuroendocrine Tumours","author":"WHO","year":"2022"},{"issue":"11","key":"2026060202462395300_bvag109-B14","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2026060202462395300_bvag109-B15","doi-asserted-by":"crossref","unstructured":"Kwayess R, Ajjour S, Rahme M, et al \u00a0Supplementary material for \u201cIntraoperative PTH monitoring: does sampling site orassay generation matter?\u201d [dataset]. Figshare. 2026. 10.6084\/m9.figshare.32077197.v1","DOI":"10.1210\/jendso\/bvag109"},{"key":"2026060202462395300_bvag109-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/jlpm.2018.12.03","article-title":"Parathyroid hormone results interpretation in the background of variable analytical performance","volume":"4","author":"Cavalier","year":"2019","journal-title":"J Lab Precis Med"},{"issue":"4","key":"2026060202462395300_bvag109-B17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","article-title":"A non-(1\u201384) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples","volume":"44","author":"Lepage","year":"1998","journal-title":"Clin Chem"},{"issue":"8","key":"2026060202462395300_bvag109-B18","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1210\/jc.2009-2791","article-title":"The ratio of parathyroid hormone as measured by third-and second-generation assays as a marker for parathyroid carcinoma","volume":"95","author":"Cavalier","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026060202462395300_bvag109-B19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2215\/CJN.01391005","article-title":"Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia","volume":"1","author":"Arakawa","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2026060202462395300_bvag109-B20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archsurg.141.2.129","article-title":"Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism","volume":"141","author":"Kaczirek","year":"2006","journal-title":"Arch Surg"},{"issue":"2","key":"2026060202462395300_bvag109-B21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0039-6060(03)00387-8","article-title":"Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism","volume":"135","author":"Yamashita","year":"2004","journal-title":"Surgery"},{"issue":"10","key":"2026060202462395300_bvag109-B22","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.metabol.2013.05.007","article-title":"Comparison between a second and a third generation parathyroid hormone assay in hemodialysis patients","volume":"62","author":"Gannag\u00e9-Yared","year":"2013","journal-title":"Metabolism"},{"issue":"1","key":"2026060202462395300_bvag109-B23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.surg.2020.03.024","article-title":"Intraoperative parathyroid hormone (IOPTH) assay might be better than the second-generation assay in parathyroidectomy for primary hyperparathyroidism","volume":"169","author":"Lang","year":"2021","journal-title":"Surgery"},{"key":"2026060202462395300_bvag109-B24","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5230985","article-title":"Comparison between second- and third-generation PTH assays during minimally invasive parathyroidectomy (MIP)","volume":"2020","author":"Gannag\u00e9-Yared","year":"2020","journal-title":"Int J Endocrinol"},{"issue":"6","key":"2026060202462395300_bvag109-B25","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1210\/er.2018-00220","article-title":"Clinical guidelines and PTH measurement: does assay generation matter?","volume":"40","author":"Smit","year":"2019","journal-title":"Endocr Rev"},{"issue":"4","key":"2026060202462395300_bvag109-B26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.surg.2008.07.004","article-title":"A prospective evaluation of the effect of sample collection site on intraoperative parathormone monitoring during parathyroidectomy","volume":"144","author":"Beyer","year":"2008","journal-title":"Surgery"},{"issue":"6","key":"2026060202462395300_bvag109-B27","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.amjsurg.2016.09.015","article-title":"Central venous parathyroid hormone monitoring using a novel, specific anatomic method accurately predicts cure during minimally invasive parathyroidectomy","volume":"212","author":"Edwards","year":"2016","journal-title":"Am J Surg"},{"issue":"7","key":"2026060202462395300_bvag109-B28","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/000313480707300716","article-title":"Central venous sampling for intraoperative parathyroid hormone monitoring: are peripheral guidelines applicable?","volume":"73","author":"Broome","year":"2007","journal-title":"Am Surg"},{"issue":"1","key":"2026060202462395300_bvag109-B29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.55251","article-title":"Use of albumin-adjusted calcium measurements in clinical practice","volume":"8","author":"Desgagn\u00e9s","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"Suppl 1","key":"2026060202462395300_bvag109-B30","article-title":"Analysis of central and peripheral PTH decay values in patients with primary hyperparathyroidism","volume":"91","author":"Caxeiro","year":"2025","journal-title":"Braz J Otorhinolaryngol"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvag109\/68404831\/bvag109.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/6\/bvag109\/68404831\/bvag109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/6\/bvag109\/68404831\/bvag109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:46:31Z","timestamp":1780382791000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag109\/8695326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5,6]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag109","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,5,6]]},"article-number":"bvag109"}}